Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseBrian G. Feagan, David J. Chang, Geert D’Haens et al.|Alimentary Pharmacology & Therapeutics|2015Cited by 110